Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M8,046Revenue $M576Net Margin (%)-13.7Z-Score9.8
Enterprise Value $M7,833EPS $0.2Operating Margin %-16.1F-Score4
P/E(ttm))0Cash Flow Per Share $0.0Pre-tax Margin (%)-12.4Higher ROA y-yN
Price/Book6.010-y EBITDA Growth Rate %0Quick Ratio6.9Cash flow > EarningsY
Price/Sales18.35-y EBITDA Growth Rate %0Current Ratio7.4Lower Leverage y-yN
Price/Cash Flow725y-y EBITDA Growth Rate %-80.8ROA % (ttm)-4.3Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-6.0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M146ROI % (ttm)-2.4Gross Margin Increase y-yY

Gurus Latest Trades with ALKS

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ALKSKen Fisher 2014-09-30 Add$41.54 - $51.52
($44.73)
$ 55.0123%Add 75.86%97,264
ALKSVanguard Health Care Fund 2014-06-30 Add0.13%$41.1 - $50.94
($46.06)
$ 55.0119%Add 18.45%6,135,913
ALKSKen Fisher 2014-06-30 Buy 0.01%$41.1 - $50.94
($46.06)
$ 55.0119%New holding, 55309 sh.55,309
ALKSJohn Burbank 2014-06-30 Sold Out -0.01%$41.1 - $50.94
($46.06)
$ 55.0119%Sold Out0
ALKSVanguard Health Care Fund 2014-03-31 Add0.19%$40.07 - $53.82
($47.32)
$ 55.0116%Add 41.07%5,180,238
ALKSJohn Burbank 2014-03-31 Buy 0.01%$40.07 - $53.82
($47.41)
$ 55.0116%New holding, 4651 sh.4,651
ALKSVanguard Health Care Fund 2013-12-31 Add0.1%$30.17 - $41.12
($36.93)
$ 55.0149%Add 28.18%3,672,087
ALKSVanguard Health Care Fund 2013-09-30 Add0.07%$28.66 - $35.35
($32.58)
$ 55.0169%Add 26.21%2,864,896
ALKSJoel Greenblatt 2013-09-30 Sold Out -0.03%$28.66 - $35.35
($32.58)
$ 55.0169%Sold Out0
ALKSVanguard Health Care Fund 2013-06-30 Add0.11%$22.35 - $33.72
($29.15)
$ 55.0189%Add 84.09%2,269,902
ALKSJoel Greenblatt 2013-06-30 Buy 0.03%$22.35 - $33.72
($29.15)
$ 55.0189%New holding, 26624 sh.26,624
ALKSVanguard Health Care Fund 2013-03-31 Add0.04%$18.52 - $23.81
($21.87)
$ 55.01152%Add 47.24%1,233,024
ALKSVanguard Health Care Fund 2012-03-31 Buy 0.07%$16.14 - $19.5
($16.48)
$ 55.01234%New holding, 787900 sh.787,900
ALKSJohn Burbank 2012-03-31 Sold Out -0.23%$16.14 - $19.5
($16.48)
$ 55.01234%Sold Out0
ALKSDaniel Loeb 2010-06-30 Sold Out -0.92%$10.7 - $13.75
($12.33)
$ 55.01346%Sold Out0
ALKSDaniel Loeb 2010-03-31 Buy 0.92%$9.41 - $14.01
($11.62)
$ 55.01373%New holding, 1000000 sh.1,000,000
ALKSGeorge Soros 2010-03-31 Sold Out $9.41 - $14.01
($11.62)
$ 55.01373%Sold Out0
ALKSJean-Marie Eveillard 2010-03-31 Sold Out -0.01%$9.41 - $14.01
($11.62)
$ 55.01373%Sold Out0
ALKSGeorge Soros 2009-12-31 Buy $7.58 - $9.88
($8.72)
$ 55.01531%New holding, 22800 sh.22,800
ALKSDaniel Loeb 2009-12-31 Sold Out -0.37%$7.58 - $9.88
($8.72)
$ 55.01531%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ALKS is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
ALKS Ken Fisher 2014-09-3097,2640.070.01+75.86%
ALKS Vanguard Health Care Fund 2014-09-306,223,0834.260.68+1.42%
Premium Most recent portfolio changes are included for Premium Members only!


ALKS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
FRATES JAMES MSVP & CFO, Alkermes plc 2014-11-19Sell8,000$53.862.27view
POPS RICHARD FDirector and CEO, Alkermes plc 2014-11-13Sell100,000$52.874.18view
BIBERSTEIN KATHRYN LSVP, GC, Secretary, Alks, Inc. 2014-11-11Sell15,000$52.744.44view
LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc. 2014-11-11Sell15,000$52.744.44view
FRATES JAMES MSVP & CFO, Alkermes plc 2014-11-07Sell13,303$49.9810.2view
BIBERSTEIN KATHRYN LSVP, GC, Secretary, Alks, Inc. 2014-11-06Sell20,000$50.548.98view
BREYER ROBERT ADirector 2014-11-03Sell5,000$50.0510.05view
Pugh Gordon GSVP, COO & CRO, Alkermes, Inc. 2014-10-23Sell14,577$4522.4view
POPS RICHARD FDirector and CEO, Alkermes plc 2014-10-16Sell100,000$41.1233.95view
LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc. 2014-10-14Sell15,000$40.6535.5view

Press Releases about ALKS :

    Quarterly/Annual Reports about ALKS:

    News about ALKS:

    Articles On GuruFocus.com
    wait for positive ea Apr 06 2013 
    comment on ALKS Mar 09 2013 
    Best Health Care Investor Edward Owens Buys One New Health Care Stock in First Quarter Apr 30 2012 
    Weekly CEO Sells Highlight: Herbalife, CNO Financial Group, Alkermes plc, and TransDigm Oct 08 2011 
    Alkermes Inc. Reports Operating Results (10-Q) Feb 03 2011 
    Weekly Guru Bargains Highlights: SKX, VRX, ALKS, DF, SVU Dec 05 2010 
    Alkermes Inc. Reports Operating Results (10-Q) Nov 04 2010 
    Alkermes Inc. Reports Operating Results (10-K) May 21 2010 
    Alkermes Inc. Reports Operating Results (10-Q) Feb 04 2010 
    Opportunistic Coat-tailing Jan 05 2010 

    More From Other Websites
    Alkermes’ Corporate Presentation to be Webcast at The NASDAQ OMX 31st Investor Program Nov 25 2014
    Cramer shares hazards of skepticism Nov 18 2014
    ALKERMES PLC. Files SEC form 8-K, Regulation FD Disclosure Nov 13 2014
    Alkermes’ Corporate Presentation to be Webcast at the Credit Suisse 2014 Healthcare Conference Nov 04 2014
    Alkermes’ Corporate Presentation to be Webcast at the Credit Suisse 2014 Healthcare Conference Nov 04 2014
    Alkermes Incurs Wider Q3 Loss but Revenues Grow Y/Y Oct 31 2014
    Alkermes reports 3Q loss Oct 29 2014
    Alkermes reports 3Q loss Oct 29 2014
    Alkermes Plc Earnings Call scheduled for 8:30 am ET today Oct 29 2014
    ALKERMES PLC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Oct 29 2014
    Q3 2014 Alkermes Plc Earnings Release - Before Market Open Oct 29 2014
    Alkermes plc Reports Third Quarter 2014 Financial Results Oct 29 2014
    Alkermes plc Reports Third Quarter 2014 Financial Results Oct 29 2014
    Alkermes to Host Conference Call to Discuss Third Quarter 2014 Financial Results Oct 22 2014
    Alkermes to Host Conference Call to Discuss Third Quarter 2014 Financial Results Oct 22 2014
    Alkermes to Host Conference Call to Discuss Third Quarter 2014 Financial Results Oct 22 2014
    Alkermes’ New Drug Application for Aripiprazole Lauroxil for Treatment of Schizophrenia Accepted... Oct 22 2014
    Alkermes’ New Drug Application for Aripiprazole Lauroxil for Treatment of Schizophrenia Accepted... Oct 22 2014
    Cramer's favorite large cap biotech plays Sep 24 2014
    ALKERMES PLC. Files SEC form 8-K, Regulation FD Disclosure Sep 24 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK